Health & Fitness
Mon, January 9, 2012Sun, January 8, 2012Sat, January 7, 2012Fri, January 6, 2012Thu, January 5, 2012Wed, January 4, 2012Tue, January 3, 2012Mon, January 2, 2012Sat, December 31, 2011Fri, December 30, 2011Thu, December 29, 2011Wed, December 28, 2011Tue, December 27, 2011Mon, December 26, 2011Fri, December 23, 2011Thu, December 22, 2011ISTA Pharmaceuticals to Present at the 14th Annual Needham Growth Conference
Published in Health and Fitness on Tuesday, January 3rd 2012 at 13:07 GMT by Market Wire
January 03, 2012 16:01 ET
ISTA Pharmaceuticals to Present at the 14th Annual Needham Growth Conference
ISTA Reminds Investors of Its Upcoming 2012 Guidance and Pipeline Update Webcast/Conference Call Scheduled on January 4, 2012
IRVINE, CA--(Marketwire - Jan 3, 2012) - ISTA Pharmaceuticals, Inc. (
The presentation will be webcast. To access the live audio broadcast of the presentation, or the subsequent archived recording, log onto [ http://www.istavision.com/investors.html ]. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
In addition, the Company reminded investors of its previously announced 2012 Guidance and Pipeline Update Webcast/Conference Call scheduled for January 4, 2012 at 4:30 p.m. ET.
Webcast and Conference Call access:
Internet: [ http://www.istavision.com/investors.html ]
Domestic dial-in: 866-270-6057
International dial-in: 617-213-8891
Passcode: 58694464
The webcast/conference call will be webcast live and archived on ISTA's website until February 1, 2012. To access the 24-hour audio replay, U.S. and Canadian participants may dial 1-888-286-8010; international participants may dial 1-617-801-6888. The access code for the replay is 75601206.
ABOUT ISTA PHARMACEUTICALS
ISTA Pharmaceuticals, Inc. is a fast growing and the third largest branded prescription eye care business in the United States, with an expanding focus on allergy therapeutics. ISTA currently markets four products, including treatments for ocular inflammation and pain post-cataract surgery, glaucoma and ocular itching associated with allergic conjunctivitis. The Company's development pipeline contains additional candidates in various stages of development to treat dry eye, ocular inflammation and pain, and nasal allergies. Headquartered in Irvine, California, ISTA generated revenues of $156.5 million in 2010. For additional information about ISTA, please visit the corporate website at [ www.istavision.com ].
